Lumbar Disc Disease
1
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
BioRestorative TherapiesBRTX-100
Globus MedicalExcelsiusGPS™
Clinical Trials (2)
Total enrollment: 200 patients across 2 trials
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
Start: Jun 2022Est. completion: Dec 2027
Phase 2Recruiting
Prospective Robotic Global Research Study (PROGRESS)
Start: Dec 2019Est. completion: Dec 2021200 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 200 patients
2 companies competing in this space